Summary
To investigate pathogenic mechanisms in experimental autoimmune myasthenia gravis (EAMG) and myasthenia gravis (MG), we studied the acute and chronic effects in rats of injection of rat monoclonal antibodies (MCABs) directed against the acetylcholine receptor (AChR). Animals were severely weak 12 h after a single injection, at which time macrophages were found invading endplate regions of muscle and cholinesterase-stained regions were separted from the underlying muscle fibers. Ultrastructural studies showed findings identical to the acute phase of EAMG: degenerating postsynaptic membranes and invasion and phagocytosis of endplate regions by macrophages. Animals receiving sublethal doses of MCAB recovered clinically by 4–5 days after injection. Recovery was accompanied by a progressive decrease in the number of macrophages associated with endplates and reapposition to the myofibers of the cholinesterasestained regions. Animals injected once, or repeatedly over several months, remained clinically and electromyographically normal after recovery from the initial episode of weakness, but their endplate ultrastructure was highly simplified with blunted or absent synaptic folds and shallow or absent secondary synaptic clefts. These studies demonstrate that anti-AChR MCABs can induce the changes of both acute and chronic EAMG. There is good correlation between the inflammatory changes and the acute clinical disease but poor correlation between morphological and clinical parameters in the chronic syndrome. The latter observation suggests that severe ultrastructural changes, similar to those seen in chronic EAMG and MG, cannot account, at least in rats, for the clinical and electrophysiologic abnormalities of MG.
Similar content being viewed by others
References
Abramsky O, Aharonov A, Webb C, Fuchs S (1975) Cellular immune response to acetylcholine receptor-rich fraction in patients with myasthenia gravis. Clin Exp Immunol 19:11–16
Bevan S, Kuhlberg RW, Heinemann SF (1977) Human myasthenia sera reduce acetylcholine sensitivity of human muscle cells in tissue culture. Nature 267:263–265
Burres AS, Crayton JW, Gomez CM, Richman DP (1981) Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: Clinical and electrophysiological aspects. Ann Neurol 9:563–568
Conti-Tronconi BC, Morgutti M, Sghirlanzoni A, Clementi F (1979) Cellular immune response against acetylcholine receptor in myasthenia gravis: Relevance to clinical course and pathogenesis. Neurology 29:496–501
Drachman D (1978) Myasthenia gravis, part 1: Pathophysiology and immunopathogenesis. N Engl J Med 298:136–141
Drachman D (1978) Myasthenia gravis, part 2: Clinical correlations and treatment. N Engl J Med 298:186–198
Drachman DB, Adams RN, Josifek LF (1982) Functional activities of anti-AChR antibodies and clinical severity of myasthenia gravis. Neurology 32:A221
Drachman D, Adams RN, Josifek LF, Self SG (1982) Functional activities of auto-antibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 307:769–775
Drachman D, Angus C, Adams R, Michelson JD, Hoffmann BM (1978) Myasthenic antibodies crosslink acethylcholine receptors to accelerate degradation. N Engl J Med 298:1116–1122
Dwyer DS, Kearny JF, Bradley RJ, Kemp GE, Oh SJ (1981) Interaction of human antibody and murine monoclonal antibody with muscle acetylcholine receptor. Ann NY Acad Sci 377:143–157
Engel AG, Lambert EH, Howard FM (1977) Immune complexes (IgG and C3) at the motor endplate in myasthenia gravis: Ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 52:267–280
Engle AG, Lindstrom JM Lambert EH, Lennon VA (1977) Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology 27:307–315
Engel AG, Sakakibara H, Sahashi K, Lindstrom JM, Lambert EH, Lennon VA (1979) Passively transferred experimental autoimmune myasthenia gravis. A study of endplate ultrastructure and binding of immune complexes. Neurology 29:179–188
Engel AG, Santa T (1971) Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann NY Acad Sci 183:46–63
Engel AG, Tsujihata MT, Lambert EH, Lindstrom JM, Lennon VA (1976) Experimental autoimmune myasthenia gravis: A sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlation. J Neuropathol Exp Neurol 35:569–587
Fambrough DM, Drachman DB, Satyamurti S (1973) Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182:293–295
Fumagalli G, Engel AG, Lindstrom J (1982) Ultrastructural aspects of acetylcholine receptor turnover at normal end-plate and in autoimmune myasthenia gravis. J Neuropathol Exp Neurol 41:567–579
Geha RS (1981) Regulation of immune responses by idiotypicantiidiotypic interactions. New Engl J Med 305:25–38
Gomez CM, Richman DP (1982) Acetylcholine receptor monoclonal antibodies specific for the alpha-bungarotoxin binding site induce acute paralysis. Neurology 32:A221
Gomez CM, Richman DP (1983) Anti-acetylcholine receptor antibodies directed against the α-bungarotoxin binding site induce a unique form of experimental myasthenia. Proc Natl Acad Sci USA 80:4089–4093
Gomez CM, Richman DP (in preparation)
Gomez CM, Richman DP, Berman PW, Burres SA Arnason BGW, Fitch FW (1979) Monoclonal antiacetylcholine receptor antibodies: Evidence for multiple pharmacological specificities. Presented at the 63rd Annual Meeting of the Federation of American Societies for Experimental Biology, Dallas, TX
Gomez C, Richman D, Berman P, Burres SA, Arnason BGW, Fitch FW (1979) Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochem Biophys Res Commun 88:575–582
Gomez C, Richman D, Berman P, Burres SA, Arnason BGW, Fitch FW (1981) Monoclonal antiacetylcholine receptor antibody: Antibody specificity and effect of passive transfer. Ann NY Acad Sci 377:97–109
Gomez C, Richman D, Wollmann R, Berman P, Arnason BG (1980) Passive transfer of experimental autoimmune myasthenia gravis using monoclonal antiacetylcholine receptor antibodies. Neurology [Abstr] 30:388
Gomez CM, Wollmann RL, Richman DP (1982) Monoclonal antibody to acetylcholine receptor produces simplified endplate architecture. Neurology [Abstr] 32:A221
Granato DA, Fulpius BW, Moody JF (1976) Experimental myasthenia in Balb/c mice immunized with rat acetylcholine receptor from rat denervated muscle. Proc Natl Acad Sci USA 73:2872–2876
Green DPL, Miledi R, Vincent A (1975) Neuromuscular transmission after immunization against acetylcholine receptors. Proc R Soc Lond [Biol] 189:57–68
Heilbronn E, Mattsson C (1974) The nicotinic cholinergic receptor protein: Improved purification method, preliminary amino acid composition and observed auto-immune response. J Neurochem 22:315–317
Heinemann S, Merlie J, Lidstrom J (1978) Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera. Nature 274:65–68
Kao I, Drachman D (1977) Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science 196:527–529
Lambert EH, Lindstrom JM, Lennon VA (1976) End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann NY Acad Sci 274:300–318
Lefvert AK, Bergstrom K (1978) Acetylcholine receptor antibody in myasthenia gravis: purification and characterization. Scand J Immunol 8:525–533
Lefvert AK, Bergstrom K, Matell G, Osterman PO, Pirskanen R (1978) Determination of acetylcholine receptor antibody in myasthenia gravis: Clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry 41:394–403
Lennon VA, Lambert EH (1980) Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285:238–240
Lennon VA, Lambert EH (1981) Monoclonal auto-antibodies to acetylcholine receptor: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann NY Acad Sci 377:77–95
Lennon VA, Lindstrom JM, Seybold ME (1975) Experimental autoimmune myasthenia: A model in rats and guinea pigs. J Exp Med, 141:1365–1375
Lennon VA, Lindstrom JM, Seybold ME (1976) Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann NY Acad Sci 274:283–299
Lennon VA, Seybold ME, Lindstrom JM, Cochrane C, Ulevitch R (1978) Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 147:973–983
Lindstrom JM, Einarson BL, Lennon VA, Seybold ME (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis: Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis. J Exp Med 144:726–738
Lindstrom JM, Engel AG, Seybold ME, Lennon VA, Lambert EH (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J Exp Med 144:739–753
Lindstrom JM, Lambert EH (1978) Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology 28:130–138
Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane D (1976) Antibody to acetylcholine receptor in myasthenia gravis: prevalence clinical correlates, and diagnostic value. Neurology (Minneap) 26:1054–1059
Möller G (1976) Biology of complement and complement receptors. Transplant Rev 32:1–165
Namba T, Nakamura T, Grob D (1967) Staining for nerve fiber and cholinesterase activity in fresh frozen sections. Am J Clin Pathol 47:75–77
Noguchi S, Drachman DB, Adams RN, Hirsch RL (1980) Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis. Ann Neurol 8:32–37
Patrick J, Lindstrom J (1973) Autoimmune response to acetylcholine receptor. Science 180:871–872
Reiness CG, Weinberg CB, Hall ZW (1978) Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle. Nature 274:68–70
Richman DP, Gomez CM, Berman PW, Burres SA, Fitch FW, Arnason BG (1980) Monoclonal antiacetylcholine receptor antibodies can cause experimental myasthenia. Nature 286:738–739
Richman, DP, Patrick J, Arnason BGW (1976) Cellular immunity in myasthenia gravis: Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med 294:694–698
Simpson JA (1960) Myasthenia gravis: a new hypothesis. Scott Med J 5:419–436
Sobashi K, Engel AG, Lindstrom JM, Lambert EH, Lennon VA (1978) Ultrastructural localization of immune complexes (IgG and C3 at the endplate in experimental autoimmune myasthenia gravis. J Neuropathol Exp Neurol 37:212–223
Tarrab-Hazdai R, Aharanov A, Silman I, Fuch S, Abramsky O (1975) Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor. Nature 256:128–130
Toyka, KV, Birnberger KL, Anzel AP, Schlegel C, Besinger U, Struppler A (1978) Myasthenia gravis: Further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model. J Neurol Neurosurg Psychiatry 41:746–753
Tzartos SJ, Lindstrom JM (1980) Monoclonal antibodies used to probe acetylcholine receptor structure: Localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 77:755–759
Yam LT, Li CY, Crosby WH (1971) Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283–290
Author information
Authors and Affiliations
Additional information
Supported in part by grants from the Muscular Dystrophy Association and the National Institutes of Health (NS15462, A19268)
Rights and permissions
About this article
Cite this article
Gomez, C.M., Wollmann, R.L. & Richman, D.P. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Acta Neuropathol 63, 131–143 (1984). https://doi.org/10.1007/BF00697195
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00697195